# Colorke (Suzhou) Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/colorke-suzhou-biotechnology-co

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.colortechbio.com
- Total disclosed funding: $24M
- Latest round: Series B (Dec 20, 2021)
- Investors on record: 8

## About

Based in Suzhou, China, and established in 2018, Colorke (Suzhou) Biotechnology Co., Ltd is a biotechnology company that focuses on molecular detection and protein detection reagents. In July 2021, the company raised series A++ funding from investors.

The company has a self-develop core technology platform µ-MFP (Micro-scaled Multi-Physics coupled Force). Besides, the company has built multiple application platforms on this platform such as ultra-high sensitivity biomolecular detection platform, multiple magnetic fluorescents coded microsphere platform, and high-throughput single-cell parallel control platform.

## Funding rounds

- Series B, Dec 20, 2021, $24M — Legend Capital, IDG Capital, China Merchants Capital, HighLight Capital, CS Capital
- Series A, Jul 5, 2021 — IDG Capital, PKI Ventures
- Series A, May 28, 2021 — IDG Capital, Laurel Venture
- Series A, Dec 18, 2020 — IDG Capital, BrightGene Bio-Medical Technology Co., Ltd.

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A, Series B
- BrightGene Bio-Medical Technology Co., Ltd. — Series A
- Laurel Venture (https://capitalatlas.ai/funds/laurel-venture) — Series A
- PKI Ventures — Series A
- Legend Capital — Series B
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series B
- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Series B
- CS Capital — Series B